Molecular Screening Testing for Colorectal Cancer
نویسندگان
چکیده
منابع مشابه
Molecular screening testing for colorectal cancer.
Worldwide, colorectal cancer is diagnosed in f1 million individuals each year, accounting for >9% of all new cancer cases (1). Approximately 529,000 people worldwide die of this disease annually. In 2006, it is estimated that 146,000 cases of colorectal cancer will occur in the United States with 55,000 deaths (2). Colorectal cancer is an excellent candidate for population-based screening becau...
متن کاملFecal Molecular Markers for Colorectal Cancer Screening
Despite multiple screening techniques, including colonoscopy, flexible sigmoidoscopy, radiological imaging, and fecal occult blood testing, colorectal cancer remains a leading cause of death. As these techniques improve, their sensitivity to detect malignant lesions is increasing; however, detection of precursor lesions remains problematic and has generated a lack of general acceptance for thei...
متن کاملRole of Molecular Biomarkers in Colorectal Cancer
Colorectal cancer (CRC) is amongst the most widespread cancers and is a most common cause of cancer associated mortality universally. Since previous decades, it has been cleared that CRC develops owing to the buildup of a series of genetic and epigenetic changes in the normal colonic epithelium. Regardless of the current development in surgery and therapies, overall survival of end stage CRC pa...
متن کاملScreening for colorectal cancer with fecal occult blood testing.
153 SCREENING FOR COLORECTAL CANCER WITH FECAL OCCULT BLOOD TESTING AND COLONOSCOPY: CORRELATION OF CLINICAL DATA, SITE, SIZE AND DISEASE’S STAGE Iuliana Taraşi, Gabriela Florenţa Dumitrescu, Anca Indrei, P. Plămădeală, Anca Trifan, C. Stanciu, 1 Departament of Gastroenterology, „St. Spiridon” Emergency Clinical Hospital Iaşi 2 Department of Pathology, „Prof. Dr. N. Oblu” Emergency Clinical Hos...
متن کاملFecal occult blood testing for colorectal cancer screening.
BACKGROUND Hemoccult II, a widely used guaiac test for fecal occult blood, has a low sensitivity for detecting colorectal neoplasms in asymptomatic patients at average risk. In such patients, the performance characteristics of screening tests developed to improve on Hemoccult II are not known. METHODS A set of three fecal occult-blood tests--Hemoccult II; Hemoccult II Sensa, a more sensitive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2006
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-06-0578